Loading patent…
AssigneeKorea Institute of Oriental Medicine
InventorsA Yeong LEE, Jun LEE, Mee Hyun LEE, Byeong Cheol MOON, Hyo Seon KIM, Young Hye SEO, Seung Mok RYU, Hyeon Hwa NAM
Estimating the term…
The present invention relates to a novel compound derived from Loranthus tanakae and an anticancer use thereof. More specifically, the present invention provides: lotanoside B (indicated as rhamnetin-3-O-Rhamnoside-4′-O-(6″-O-cinnamoyl)-glucoside(Rhamnetin-3-O-rhamnoside-4′-O-(6″-O-cinnamoyl)-glucoside according to the IUPAC nomenclature) that is represented by formula 1 below; an isomer or pharmaceutically acceptable salt thereof; a pharmaceutical composition and functional health food composition containing same; and a method for separating lotanoside B represented by formula 1 below and/or rhamnetin-3-O-glucoside represented by formula 2 below.
Lotanoside B represented by Chemical Formula 1, an isomer thereof or a pharmaceutically acceptable salt thereof:
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A method for isolating Lotanoside B represented by Chemical Formula 1 below and/or rhamnetin-3-O-glucoside represented by Chemical Formula 2 below from Loranthus tanakae Franch. & Sav, the method comprising:
(canceled)
(canceled)
Dependencies are inferred from the claim text.